Semaphorin 3A as a diagnostic marker for urothelial cancer
US10139412B2 · kind B2 · utility
6Cited by
0References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 2, 2014 |
| Grant date | Nov 27, 2018 |
| Priority date | — |
| Expiry date | Dec 2, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is directed to methods and kits useful for diagnosis and/or prognosis of urothelial cancer in a subject. The present invention further relates to methods of assessing severity of cancer and methods of determining efficacy of a treatment for cancer. The methods and kits of the invention comprise determining the levels of semaphorin 3A in a biological sample of a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.